PTPN11 and liver dysplastic nodule: Moreover, we took advantage of an immune-complex phosphatase assay to measure SHP2 activity in kidney biopsy samples with DN, and found that SHP2 activity was indeed increased significanlty (nearly 3.2-fold) in DN as compared with normal ones (Fig. 1E), further proving that SHP2 activity is strengthened in DN.